fda statement on compounded semaglutide 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Fifth Circuit probes FDA ban

If you're in the smaller leagues, your best play is blood testing your patients

Avexitide is designed to bind to the GLP-1 receptor on pancreatic islet beta cells and inhibit the effect of GLP-1 to mitigate hypoglycemia by decreasing insulin secretion and stabilizing blood glucose levels

In -cells, GLP-1(936) activates GLP-1R, increasing cAMP and activating PKA and CREB to promote insulin secretion

For men who can afford out-of-pocket treatment, direct access eliminates the bureaucratic obstacles that delay care

Well talk about some that did in a little bit

Legitimate policy conversations are needed about marketing practices, guardrails and consistent standards